Navigation Links
Neogen Partners With Chinese Government
Date:6/2/2009

LANSING, Mich., June 2 /PRNewswire-FirstCall/ -- Neogen Corporation (Nasdaq: NEOG) announced today that its Scotland-based European subsidiary has signed a partnership agreement with the Chinese government to research China-specific food safety and plant health issues.

The partnership agreement created a jointly funded laboratory in Beijing. Testing methods and data developed in this lab will be used by more than 30 other labs throughout China.

"This agreement represents a great opportunity for Neogen to be at the forefront in helping develop food safety and plant health solutions specifically for the Chinese," said James Herbert, Neogen's CEO. "This opportunity is a logical expansion of Neogen Europe's proven ability to tailor solutions to the varying regulatory and quality assurance environments in the large number of countries it serves."

A recent high-level meeting between Chinese Minister of Quality Supervision, Inspection and Quarantine, Wang Yong, Scotland's First Minister, the United Kingdom's Ambassador to China, Sir William Ehrman, and Neogen representatives, led to the final agreement.

"This is fantastic news for Neogen Europe, Scottish jobs and businesses and for our international reputation," said Scotland's First Minister Alex Salmond, in a news release. "The pace of progress following our meeting with Mr. Yang in China last month is a remarkable testament to the impressive work of Neogen Europe, the potential for Scottish businesses in China and the lasting cooperation built."

According to the Scottish government, the agreement is expected to bring an economic boost of more than 10 million pounds to Scotland, paving the way for increased exports to China, driving expansion in Scotland and solidifying Scotland's reputation for world-leading sciences.

The company's Neogen Europe subsidiary, based in Ayr, Scotland, does research and development of diagnostic tests for plant diseases and food safety, and also markets products from other Neogen locations. Neogen Europe was honored last year with the Queen's Award for Enterprise -- the most prestigious business award in the United Kingdom.

Neogen Corporation develops and markets products dedicated to food and animal safety. The company's Food Safety Division markets dehydrated culture media, and diagnostic test kits to detect foodborne bacteria, natural toxins, genetic modifications, food allergens, drug residues, plant diseases and sanitation concerns. Neogen's Animal Safety Division markets a complete line of diagnostics, veterinary instruments, veterinary pharmaceuticals, nutritional supplements, disinfectants, and rodenticides.

Certain portions of this news release that do not relate to historical financial information constitute forward-looking statements. These forward-looking statements are subject to certain risks and uncertainties. Actual future results and trends may differ materially from historical results or those expected depending on a variety of factors listed in Management's Discussion and Analysis of Financial Condition and Results of Operations in the Company's most recently filed Form 10-K.


'/>"/>
SOURCE Neogen Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Neogen Acquires Kane Enterprises
2. Neogen Reports 25% Increase in Net Income, 13% Increase in Revenues
3. Neogen Acquires Assets of Rivard Instruments
4. Neogen Reports 34% Increase in Net Income, 23% Increase in Revenues
5. Neogen Launches Quickest Test Available for Tetracyclines in Milk
6. NeoGenomics Announces Results for the Fourth Quarter and Full Year FY 2007
7. Webcast Alert: Neogen Corporation Announces 3rd Quarter Results
8. Neogen Reports 34% Increase in Net Income, 20% Increase in Revenues
9. NeoGenomics Files Annual Report on Form 10-KSB with the SEC
10. NeoGenomics Schedules Its Q1 2008 Earnings Release for May 7, 2008
11. Neogen Forms Mexican Subsidiary
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... , Jan. 17, 2017  Protagonist Therapeutics, Inc. ... it has initiated a global Phase 2b induction ... peptide that targets alpha4beta7 integrin. The aim of ... to evaluate the safety/tolerability and efficacy of PTG-100 ... moderate to severe active disease. ...
(Date:1/16/2017)... ... January 16, 2017 , ... Attagene , a Research ... U.S. Small Business Administration. The Tibbetts Award honors the Small Business Innovation ... and are considered the best of the best from the thousands of firms ...
(Date:1/13/2017)... -- Research and Markets has announced the addition of ... to 2021" report to their offering. ... The biosimilars market is expected to ... 2016, at a CAGR of 26.3%. The global ... and application. Factors such as rising incidence of various diseases, increasing ...
(Date:1/13/2017)... Island, NY (PRWEB) , ... January 13, 2017 ... ... teamed up with several companies to offer its customers three new solutions for ... probe would come in handy if a customer has an oddly-shaped sample that ...
Breaking Biology Technology:
(Date:12/22/2016)... SuperCom (NASDAQ:   SPCB ... e-Government, Public Safety, HealthCare, and Finance sectors announced today that Leaders ... to implement and deploy a community-based supportive services program to reduce ... , further expanding its presence in the state. ... This new program, which is expected ...
(Date:12/16/2016)...   IdentyTechSolutions America LLC , a leading ... and a cutting-edge manufacturer of software and hardware ... seamless, integrated solutions that comprise IDT biometric readers ... provide IdentyTech,s customers with combined physical identification and ... and theft. "We are proud to ...
(Date:12/15/2016)... , Dec. 15, 2016   WaferGen Bio-systems, ... held genomics technology company, announced today that on December ... Qualifications Department of The Nasdaq Stock Market LLC which ... bid price of WaferGen,s common stock had been at ... WaferGen has regained compliance with Listing Rule 5550(a)(2) of ...
Breaking Biology News(10 mins):